HKD 2.33
(2.19%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 2.8 Million CNY | 126.43% |
2022 | -103.1 Million CNY | -212.7% |
2021 | 90.17 Million CNY | 4.31% |
2020 | 81.76 Million CNY | 1073.83% |
2019 | -9.27 Million CNY | -112.94% |
2018 | 67.9 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 10.25 Million CNY | 0.0% |
2024 Q1 | 10.25 Million CNY | 368.73% |
2023 Q2 | 6.68 Million CNY | 0.0% |
2023 FY | - CNY | 126.43% |
2023 Q4 | -3.81 Million CNY | 0.0% |
2023 Q3 | -3.81 Million CNY | -157.07% |
2023 Q1 | 6.68 Million CNY | 123.85% |
2022 Q3 | -26.75 Million CNY | -77.32% |
2022 Q2 | -15.08 Million CNY | 0.0% |
2022 Q1 | -15.08 Million CNY | -639.53% |
2022 FY | - CNY | -212.7% |
2022 Q4 | -28.02 Million CNY | -4.75% |
2021 Q1 | 38.29 Million CNY | 18.86% |
2021 Q4 | 2.79 Million CNY | 0.0% |
2021 Q3 | 2.79 Million CNY | -92.7% |
2021 Q2 | 38.29 Million CNY | 0.0% |
2021 FY | - CNY | 4.31% |
2020 FY | - CNY | 1073.83% |
2020 Q4 | 32.21 Million CNY | -2.77% |
2020 Q3 | 33.13 Million CNY | -24.75% |
2020 Q2 | 44.03 Million CNY | 0.0% |
2020 Q1 | 44.03 Million CNY | 0.0% |
2019 FY | - CNY | -112.94% |
2018 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 22.91 Million HKD | 87.775% |
Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 99.118% |
China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -38.048% |
Prosperous Future Holdings Limited | -19.68 Million HKD | 114.228% |
Huasheng International Holding Limited | 19.67 Million HKD | 85.766% |
Fourace Industries Group Holdings Limited | 61.52 Million HKD | 95.447% |
Evergreen Products Group Limited | 140.78 Million HKD | 98.01% |
EC Healthcare | 737.83 Million HKD | 99.62% |
Ming Fai International Holdings Limited | 211.83 Million HKD | 98.678% |
Blue Moon Group Holdings Limited | 656.37 Million HKD | 99.573% |
SuperRobotics Holdings Limited | -7.39 Million HKD | 137.856% |
Takbo Group Holdings Limited | 25.8 Million HKD | 89.145% |
Hyfusin Group Holdings Limited | 154.18 Million HKD | 98.183% |